Johnson & Johnson, the pharmaceutical giant with a 3.21% dividend yield, released financial results for Q2 2024 that exceeded my expectations.Its oncology franchise revenue was $5.09 billion for the ...
Source LinkJohnson & Johnson, the pharmaceutical giant with a 3.21% dividend yield, released financial results for Q2 2024 that exceeded my expectations.Its oncology franchise revenue was $5.09 billion for the ...
Source Link
Comments